Poland· PL-100021447

Effox long 50

A isosorbide mononitrate product containing isosorbidi mononitras, registered in Poland by Merus Labs Luxco II S.a R.L.. The same ATC class is registered in 13 of our 19 countries.

ATC C01DA14

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedEffox long 50ATCC01DA14REGISTER NO.PL-100021447PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Isosorbide mononitrate is registered in 13 of 19 countries.

Countries holding a registration under ATC C01DA14 (isosorbide mononitrate), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Isosorbide mononitrate · ATC C01DA14

13 / 19 countries

  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of isosorbide mononitrate costs, country by country.

Normalised to the WHO defined daily dose (40 mg), the median price runs from $0.078 in United States to $0.15 in Italy — a ×1.9 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Isosorbide mononitrate · price per daily dose (40 mg)

USD · FX 28 Sept 2026

  • IT Italy$0.15
  • US United States$0.078 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Isosorbidi mononitras
Manufacturer
Merus Labs Luxco II S.a R.L.
Country
Poland (PL)
ATC code
C01DA14
ATC class
Isosorbide mononitrate
Defined daily dose
40 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909990368617
  • gtin
    05909990368624
  • gtin
    05909990368648
  • gtin
    05909990368631

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

275 interactions on record for isosorbide mononitrate.

Graded by severity as the source publishes them — 71 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Isosorbide mononitrate · interactions on record

275 records

  • 71 moderate
  • 1 minor
  • 198 info

Most severe, free to view

  • LidocainA01AE01moderate
  • TetracainA01AE02moderate
  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Isosorbide mononitrate in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All isosorbide mononitrate products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Ismn Genericon, Monoket Retard
  • Bulgaria · Oликард, Изосорб
  • Cyprus · Imdur, Monorem
  • Czechia · Mono Mack Depot, Monosan
  • Germany · Elantan Long, Is 5 Mono
  • Denmark · Farmidur, Fem-Mono Retard
  • Estonia · Imdur, Isomonit
  • Spain · Coronur, Coronur Retard
  • Finland · Imdur, Isangina
  • United Kingdom (Northern Ireland) · Angitate, Carmil Xl
  • Greece · Dilavase, G-Dil
  • Croatia · Ismn Genericon, Isocard
  • Hungary · Mono Mack Depot, Olicard
  • Ireland · Elantan, Elantan La
  • Iceland · Fem-Mono Retard, Imdur
  • Italy · Duronitrin, Elan
  • Lithuania · Imdur, Ismn Stada
  • Latvia · Imdur, Ismn Stada
  • Malta · Imdur, Monorem R
  • Netherlands · Isosorbide Mononitraat Retard Rph, Isosorbide Mononitraat Retard Viatris
  • Norway · Imdur, Isomex
  • Portugal · Imdur, Ismo
  • Romania · Mononitron Ep, Olicard Retard
  • Sweden · Imdur, Ismo
  • Slovenia · Monosan, Olicard
  • Slovakia · Mono Mack Depot, Monosan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/94d26122-11fa-4dfc-9c85-6abe4657d4bd
GET /v1/drugs/94d26122-11fa-4dfc-9c85-6abe4657d4bd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki o przedłużonym uwalnianiu",
  "source": "urpl",
  "strength": "50 mg",
  "packaging": "05909990368617 ¦ Rp ¦ Skasowane ¦ 3546\n20 tabl.\n05909990368624 ¦ Rp ¦ 3547\n30 tabl.\nRp ¦ Skasowane ¦ 3548\n50 tabl.\n05909990368648 ¦ Rp ¦ 3549\n100 tabl.\n05909990368631 ¦ Rp ¦ 15995\n60 tabl.",
  "substance": "Mieszanina monoazotanu izosorbidu z laktozą (90/10) 55.556 mg",
  "common_name": "Isosorbidi mononitras",
  "pl_product_id": "100021447",
  "pozwolenie_nr": "03686",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about isosorbide mononitrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.